PEN

Penumbra
NYSE

实时行情|Nasdaq Last Sale

161.83
+8.22
+5.35%
已收盘, 16:13 04/02 EDT
开盘
153.37
昨收
153.61
最高
162.29
最低
149.23
成交量
23.38万
成交额
--
52周最高
194.93
52周最低
121.80
市值
56.73亿
市盈率(TTM)
121.07
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测PEN价格均价为187.60,最高价位200.00,最低价为180.00。

EPS

PEN 新闻

更多
  • 特朗普推动减产之际 OPEC+将于下周一举行网络会议
  • 新浪财经 · 39分钟前
  • 22亿财务造假“连环炸”!央视记者探访瑞幸北京总部
  • 新浪科技综合 · 42分钟前
  • 瑞幸不幸!门店遭消费挤兑 神州系暴跌!“受害人”名单在拉长
  • 新浪财经综合 · 47分钟前
  • 日本拟向收入减少家庭发放30万日元
  • 新浪财经综合 · 49分钟前

所属板块

医疗设备、用品及经销
+2.77%
医疗设备和用品
+3.33%

热门股票

代码
价格
涨跌幅

PEN 简况

Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. It focuses on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. Its neuro products include Neurovascular Access, Neuro Thrombectomy (Ischemic Stroke), Neurovascular Embolization (Brain Aneurysms) and Neurosurgical Tools (Hemorrhagic Stroke). Its peripheral vascular products include Peripheral Vascular Embolization and Peripheral Thrombectomy.
展开

微牛提供Penumbra Inc(NYSE-PEN)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的PEN股票新闻,以帮助您做出投资决策。